China approves ethnobotany seaweed-based Alzheimer’s drug. It’s the first new one in 17 years. November 4, 2019 by timbatchelder, posted in Social Business https://amp.cnn.com/cnn/2019/11/03/health/china-alzheimers-drug-intl-hnk-scli/index.html Rate this:Share this:EmailTumblrFacebookRedditLinkedInPrintPocketPinterestTwitterWhatsApp Related
